Writer's block: preventing m

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Targeting intracellular mRNA mJournal of advanced research · 2026
   Review
2. Key mBMC medical genomics · 2023
   Article
3. NCellular & molecular immunology · 2023
   Article
4. The function of Wtap in NNature immunology · 2022
   Article
5. Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia.Biomedicines · 2021
   Review
6. The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer.Journal of inflammation research · 2021
   Review
7. The RNA modification NNature immunology · 2020
   Review
8. RNA NJournal of immunology research · 2020
   Review

Corrections and comments

• Comment on
  m2017

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as